Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Nat Commun ; 13(1): 835, 2022 02 11.
Article in English | MEDLINE | ID: mdl-35149709

ABSTRACT

The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.


Subject(s)
BRCA1 Protein/metabolism , BRCA2 Protein/metabolism , Carcinoma, Ovarian Epithelial/immunology , Cystadenocarcinoma, Serous/immunology , Ovarian Neoplasms/immunology , Tumor Microenvironment/immunology , BRCA1 Protein/genetics , BRCA2 Protein/genetics , CD4-Positive T-Lymphocytes , CD8-Positive T-Lymphocytes , Carcinoma, Ovarian Epithelial/genetics , Cystadenocarcinoma, Serous/genetics , Female , Genes, BRCA1 , Genes, BRCA2 , Genotype , Homologous Recombination , Humans , Mutation , Ovarian Neoplasms/genetics , Prognosis , Proteomics
SELECTION OF CITATIONS
SEARCH DETAIL